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In Brief
Palomer et al. find that, unlike what
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respond to synaptic activity in the
hippocampus of old mice. In addition,
they show that age-associated
cholesterol loss weakens the signaling
pathway required for chromatin
remodeling and transcription of this gene.
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Cognitive capacities decline with age, an event
accompanied by the altered transcription of synaptic
plasticity genes. Here, we show that the transcrip-
tional induction of Bdnf by a mnemonic stimulus is
impaired in aged hippocampal neurons. Mechanisti-
cally, this defect is due to reduced NMDA receptor
(NMDAR)-mediated activation of CaMKII. Decreased
NMDAR signaling prevents changes associated with
activation at specific Bdnf promoters, including
displacement of histone deacetylase 4, recruitment
of the histone acetyltransferase CBP, increased
H3K27 acetylation, and reduced H3K27 trimethyla-
tion. The decrease in NMDA-CaMKII signaling
arises from constitutive reduction of synaptic choles-
terol that occurs with normal aging. Increasing the
levels of neuronal cholesterol in aged neurons
in vitro, ex vivo, and in vivo restored NMDA-induced
Bdnf expression and chromatin remodeling. Further-
more, pharmacological prevention of age-associ-
ated cholesterol reduction rescued signaling and
cognitive deficits of aged mice. Thus, reducing
hippocampal cholesterol loss may represent a thera-
peutic approach to reverse cognitive decline during
aging.INTRODUCTION
Aging is characterized by a progressive decline in cognitive ca-
pacities. It is unlikely that the decline of a complex process like
cognition arises from the altered expression or activity of a single
factor. However, changes in global regulators of gene expres-
sion, such as epigenetic mechanisms, may contribute to the
aged brain phenotype. In support of this hypothesis, epigenetic
regulatory mechanisms have been shown to be deregulated in
the aged brain and in many age-related neurodegenerative dis-
orders (Kosik et al., 2012; Peleg et al., 2010; Penner et al.,Cell Report
This is an open access article under the CC BY-N2010; Sanchez-Mut and Gra¨ff, 2015). Studies in diverse systems
have shown that reduced gene transcription in aged tissues
is associated with increased levels of repressive chromatin
marks (H3K9Me2-Me3 or H3K27Me3), decreased levels of
activating chromatin marks (H3K9Ac, H3K14Ac, H4K12Ac, or
H4K20Me1), and/or decreased levels of chromatin marks linked
to transcriptional elongation (H3K36Me3; Peleg et al., 2010;
Tang et al., 2011; Walker et al., 2013; Wang et al., 2010). In
addition, the levels of histone deacetylases (HDACs) undergo
age-associated changes (Baltan, 2012; Chouliaras et al., 2013).
Thus, deregulation of chromatin-modifying enzymes occurs in
the aging brain.
Epigenetic deregulation in the aging brain could arise from de-
fects in the signal transduction of neuronal stimuli. For example,
changes in subunit composition, localization, and/or assembly of
neurotransmitter receptors may alter their activity and down-
stream signaling. The expression levels and lipidic surroundings
of receptors change with age and affect their internalization and
lateral diffusion (Ledesma et al., 2012; Martin et al., 2014a). One
of the lipid changes that has the most profound effect on mem-
brane structure is the reduction in cholesterol content, which
was observed in the synaptic fraction of the hippocampus of
aged mice (Martin et al., 2008; Sodero et al., 2011b) and in the
hippocampus and cortex of mouse models of Alzheimer’s dis-
ease (Fabelo et al., 2012; Xie et al., 2003). Reduced cholesterol
content in the aged brain was also reported in humans, in both
non-Alzheimer’s and Alzheimer’s brain samples (Mason et al.,
1992; Molander-Melin et al., 2005; Mulder et al., 1998; Roher
et al., 2002; So¨derberg et al., 1990; Svennerholm et al., 1991,
1994, 1997; Thelen et al., 2006). In support of a direct relation-
ship between age-associated cholesterol reduction and cogni-
tive deficits, recent work demonstrated that restoring cholesterol
levels in the hippocampus of old mice is sufficient to rescue
biochemical, electrophysiological, and behavioral (cognitive)
deficits (Martin et al., 2014a). Furthermore, restoring brain
cholesterol levels rescues synaptic and cognitive dysfunction
in a mouse model of Huntington’s disease (Valenza et al.,
2015). All these data suggest that cholesterol deficiency in the
old may play a role in the epigenetic deregulation of genes
involved in learning and memory and consequently in the cogni-
tive deficits typical of this stage of life.s 16, 2889–2900, September 13, 2016 ª 2016 The Author(s). 2889
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Age-Associated Chromatin Alterations at Bdnf Promoters
(A) qRT-PCRanalysis showing the levels ofBdnfmRNAs transcribed frompromoters II andVI in hippocampus fromadult (8monthsold) and old (20monthsold)mice.
(B–G) ChIP results showing the levels of histone and regulatory proteins bound at Bdnf promoters in hippocampus from adult and old mice: (B) H3K27Me3, (C)
H3K27Ac, (D) H3K27Me3S28p, (E) CBP, and (G) HDAC4. (F) ChIP results showing the levels of H3K27Ac found at the Bdnf promoters after treatment of neuronal
cultures with the NMDAR inhibitor AP5 or with the CaMKII inhibitor KN93. The control values (untreated) taken as 1 are indicated by a dashed line.
Data are represented as mean ± SEM. Statistical analysis was performed by Student’s t test or Mann-Whitney (A–E and G) and one-sample t test (F). The value
inside the bars indicates the number of animals or independent experiments; asterisks indicate the p values (*p < 0.05; **p < 0.01; ***p < 0.001) obtained in the
comparisons of adult versus old (A–E and G) or treatments versus control conditions (F). For specific statistical analysis and data, see Experimental Procedures
and Supplemental Information.RESULTS
Epigenetic Repression of Bdnf Promoters in the
Hippocampus of Old Mice
BDNF is vital for learning and memory (Lu et al., 2014). The
Bdnf gene contains multiple promoters that are specifically
regulated by different stimuli (Aid et al., 2007). The rodent
Bdnf gene possesses structural complexity that results in mul-
tiple splicing variants. It has nine exons, eight of which have
their own promoter and are directly spliced to exon IX, the
exon containing the coding sequence (Aid et al., 2007; Liu
et al., 2006). Transcripts containing exons II and VI are rapidly
synthesized after determined neuronal stimuli and transported
to distal dendrites, where they play an important role in archi-
tectural and functional plasticity (Baj et al., 2011; Palomer
et al., 2016). We found that the levels of mRNAs containing
Bdnf exons II or VI are significantly reduced in the hippocam-
pus of 20-month-old mice compared to adult (8 months old)
mice (Figure 1A).2890 Cell Reports 16, 2889–2900, September 13, 2016To investigate why these transcripts are reduced in older
mice, we analyzed the epigenetic marks present at their
respective promoters in the hippocampus of adult and old
mice. Chromatin immunoprecipitation (ChIP) revealed that
activating (H3K27Ac) and repressive (H3K27Me3) marks co-
exist at these promoters. Both promoters were enriched (1.6-
fold) for H3K27Me3 and depleted (0.4-fold) of H3K27Ac in the
hippocampus of old mice compared to adult animals (Figures
1B and 1C). The repressive H3K27Me3 histone mark is recog-
nized by the polycomb repressor complex 1/2 (PRC1/2), lead-
ing to chromatin compaction and transcriptional inhibition
(Margueron and Reinberg, 2011). It has been reported that
phosphorylation of H3K27Me3 at Serine 28 (H3K27Me3S28p)
displaces PRC2 from chromatin, facilitating transcriptional acti-
vation (Gehani et al., 2010). By ChIP experiments, we observed
that the increase in H3K27Me3 at Bdnf promoters of old hippo-
campus is accompanied by a higher phosphorylation of at
Serine 28 (Figure 1D), suggesting that the reduced basal tran-
scription of Bdnf promoters II and VI in old neurons is not solely
explained by enhanced H3K27Me3-mediated transcriptional
repression.
It was recently shown that H3K27 acetylation at Bdnf pro-
moters II and VI in hippocampal neurons is mediated by
active CREB, which recruits the histone acetyl transferase
CBP to these promoters after NMDA receptor (NMDAR)
activation (Palomer et al., 2016). Consistent with a defect in
H3K27 acetylation in aged neurons, our ChIP experiments
revealed reduced (0.7-fold) levels of CBP at these two pro-
moters in aged hippocampus (Figure 1E). Furthermore, it has
been shown that HDAC2 regulates memory formation and
is enriched at the promoters of genes involved in synaptic re-
modeling and plasticity, including the Bdnf promoter (Guan
et al., 2009). Consistently, our ChIP results show that
hippocampal aging is accompanied by the accumulation of
HDAC2 at Bdnf promoters II and VI (Figure S1A). Altogether,
our data indicate that decreased H3K27Ac and expression
of Bdnf promoters II and VI in aged hippocampus reflect
both reduced histone acetylation and enhanced histone
deacetylation.
Reduced NMDAR Signaling Promotes Histone
Deacetylation at Bdnf Promoters
Different signaling pathwaysmay underlie the decreased levels of
CBP bound to Bdnf promoters II and VI in the hippocampus of
agedmice (describedearlier). A strongcandidate tomediate these
age-associated defects is the NMDAR-Ca2+/calmodulin-depen-
dent protein kinase II (CaMKII)-CREB pathway. It has been re-
ported that long-term depression (LTD, one of the processes un-
derlying memory formation) requires CaMKII activity (Mayford
et al., 1995; Pi et al., 2010) and that CREB activation, required
for CBP recruitment to Bdnf promoters, is dependent on CaMKII
(Palomer et al., 2016). Thus, defects in the NMDAR-CaMKII
pathway in the aged brain could lead to impairedCBP recruitment
at Bdnf promoters and consequently lower levels of H3K27 acet-
ylation. To test this hypothesis, we first analyzedwhether NMDAR
activity regulates the basal epigenetic modifications at Bdnf pro-
moters. Inhibition of NMDARs with the antagonist AP5 (Davies
and Watkins, 1982), followed by ChIP experiments, revealed that
inhibiting NMDAR reduced the level of H3K27Ac at Bdnf pro-
moters II and VI in basal conditions (Figure 1F). As expected,
CaMKII phosphorylation was also reduced when NMDARs were
inhibitedwithAP5 (FigureS2A). Thus, theNMDA-CaMKII pathway
is required for H3K27Ac at Bdnf promoters II and VI.
HDAC4 plays an important role in the transcriptional control of
synaptic plasticity and memory genes. The association of
HDAC4 with chromatin is negatively regulated by CaMKII, in
turn a target of NMDA activity (Backs et al., 2006; McKinsey
et al., 2000; Sando et al., 2012). Thus, we tested whether
HDAC4 is enriched at Bdnf promoters of the old hippocampus,
where NMDA-CaMKII activity is low. We observed a substantial
increase (3.3-fold) in HDAC4 at Bdnf promoters II and VI in hip-
pocampal nuclei obtained from old mice by ChIP (Figure 1G).
To further establish that the NMDAR-CaMKII pathway controls
H3K27 acetylation at Bdnf promoters, we treated hippocampal
neuronal cultures with KN93, a CaMKII-specific inhibitor (Sumi
et al., 1991). KN93 treatment led to reduced basal levels of
H3K27Ac at Bdnf promoters, determined by ChIP (Figure 1F).In contrast, treatment with KN92, a structural analog lacking
the ability to inhibit CaMKII, did not show any effect (Figure S2B;
Knafo et al., 2012). Altogether, our findings suggest that impaired
NMDAR-CaMKII activity contributes to the altered epigenetic
regulation of Bdnf promoters in aged neurons.
Bdnf Induction byNMDA Is Impaired in theHippocampus
of Old Mice
We next analyzed whether the response of Bdnf promoters II and
VI to NMDAR stimulation is affected by their repressive epigenetic
state in old neurons (Figure 1). Hippocampal slices obtained from
adult and old mice were stimulated with a low dose of NMDA
(20 mM), a concentration widely used to induce NMDAR-LTD (Eh-
lers, 2000; Ferna´ndez-Monreal et al., 2012; Lee et al., 1998; Lin
et al., 2000), and the level of the specific transcript was deter-
mined by qPCR. We found that NMDA triggered an increase in
mRNAs containing exons II andVI 10min after stimulation in slices
from 8-month-old mice but not in those from 20-month-old mice
(Figure 2A). NMDA treatment also led to increased levels of acti-
vating signals (H3K27Ac and CBP) at promoters II and VI in sam-
ples from the 8-month-old mice but not from old mice, observed
by ChIP (Figures 2B and 2C). Furthermore, the ChIP experiments
highlighted that NMDA-LTD leads to the depletion of HDAC4 from
these promoters in the adult but not in the old animals (Figure 2D).
Consistent with our findings that epigenetic deregulation is asso-
ciated with age-associated decreases in NMDA signaling, we
found that the NMDA-LTD stimulus triggered the activation of
CREB (Figures 2E and 2F) and CaMKII (Figures 2G and 2H) in hip-
pocampal slices obtained from adult but not old mice. We
observed that NMDAR stimulation did trigger HDAC2 depletion
from Bdnf promoters in old hippocampal slices (Figure S1B).
Therefore, the impaired induction of Bdnf promoters II and VI by
synaptic activity in the aged hippocampus correlates specifically
with the impaired induction of CaMKII-CREB-CBP signaling and
HDAC4 displacement.
Age-Associated Cholesterol Reduction Leads to Weak
NMDAR Signaling
To test whether the naturally occurring age-associated choles-
terol reduction (see Introduction; Figure 3A) plays a role in the
weak NMDAR-CaMKII signaling of old neurons, we incubated
hippocampal slices from oldmicewith a cholesterol-rich solution
(MßCD-Ch), using a protocol known to restore membrane
cholesterol levels to the adult mouse levels (Figure 3B; Martin
et al., 2014a). We performed ChIP and found that cholesterol
addition to hippocampal slices from old mice is sufficient to
induce increased levels of H3K27Ac and reduced levels of
HDAC4 at Bdnf promoters II and VI in basal, unstimulated neu-
rons (Figures 3C and 3D), resembling the epigenetic state found
in adult animals. Cholesterol-treated slices also displayed sig-
nificantly increased basal CaMKII activity (Figure 3E) and
restored levels of the histone acetyltransferase CBP at these
Bdnf promoters (Figure 3F). Moreover, the cholesterol treatment
enhanced basal CREB activity, indicated by increased phos-
phorylation at Serine 133 (Figure 3G). Therefore, adding choles-
terol to the hippocampus of old mice is sufficient to promote
epigenetic changes at Bdnf promoters II and VI associated
with activation.Cell Reports 16, 2889–2900, September 13, 2016 2891
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Figure 2. Impaired Bdnf Transcription after LTD in Hippocampal Slices from Old Mice
(A) qRT-PCR analysis in hippocampal slices showing that the levels ofBdnfmRNAs transcribed from promoters II and VI increase in adult (8 months old) but not in
old (20 months old) mice at 10 and 30 min after NMDA stimulation.
(B–D) ChIP analysis showing the levels of H3K27Ac (B), CBP (C), and HDAC4 (D) bound at Bdnf promoters 10 min after LTD induction in hippocampal slices from
adult and old mice. The data represent relative values with respect to non-stimulated controls (dashed line).
(E and F) Western blot and its quantification, showing that the levels of phospho-CREB increase in adult hippocampal slices (E) but not in old hippocampal slices
(F) 10 min after NMDA stimulation.
(G and H) Western blot and its quantification, showing that the levels of phospho-CaMKII increase in adult hippocampal slices (G) but not in old hippocampal
slices (H) 10 min after NMDA stimulation.
(legend continued on next page)
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To determine whether the effect of cholesterol was due to the
potentiation of the signaling through NMDARs, we pre-incu-
bated the cholesterol-treated, old hippocampal slices with the
NMDAR antagonist AP5. The treatment of old slices with choles-
terol and AP5 led to reduced H3K27Ac and increased HDAC4
levels, although the changes were not significant (Figure 3).
Thus, although cholesterol treatment restored the biochemical
pathways and epigenetic marks associated with gene activation
in a NMDAR activity-dependent manner (Figures 3E–3G), it did
not increase the levels of Bdnf mRNAs II and VI in the steady
state (Figure S1C), suggesting that other cholesterol-indepen-
dent regulatory mechanisms also participate in the repressive
state of Bdnf expression in the non-stimulated context.
To further substantiate that reduced levels of cholesterol affect
NMDAR signaling and the epigenome in the aged hippocampus,
we decreased the cholesterol content in hippocampal slices
from 8-month-old mice. Slices were treated with cholesterol
oxidase (COase) for 30min, a protocol previously used in our lab-
oratory to induce a mild cholesterol reduction without affecting
cell survival (Figure S2C; Brachet et al., 2015). Lowering choles-
terol levels in slices from these younger mice resulted in enrich-
ment of HDAC4 and depletion of CBP and H3K27Ac at Bdnf
promoters II and VI (Figures S2D–S2F). In agreement, lowering
cholesterol in hippocampal neurons in culture triggered CaMKII
de-phosphorylation (Figure S2A). Altogether, this suggests that
the reduction in hippocampal cholesterol could contribute to
reduced NMDAR signaling, which is in turn responsible for the
low basal CaMKII activity and the repressive chromatin status,
characterized by lower H3K27Ac levels at Bdnf promoters II
and VI.
Cholesterol Rescues LTD-Induced Bdnf Transcription in
Old Neurons
Given the observation that cholesterol treatment of old neurons
in basal, non-stimulated conditions restores an epigenetic state
at Bdnf promoters II and VI so that it is similar to that of younger,
adult hippocampus, we next tested whether exogenous choles-
terol would enhance Bdnf transcription after NMDA stimulation.
By ChIP, we found that cholesterol enrichment of hippocampal
slices from old mice was required for NMDA-induced recruit-
ment of CBP, H3K27 acetylation, and HDAC4 depletion at
Bdnf promoters II and VI (Figures 4A–4C). Furthermore, choles-
terol treatment of these slices led to NMDA-induced activation
of CaMKII and CREB (Figures 4D and 4E). More importantly,
and consistent with a true functional effect, the addition of
cholesterol rescued the impaired NMDA-induced transcription
of Bdnf promoters II and VI in old hippocampal slices, mimicking
the effect of NMDA on hippocampal slices from younger mice
(Figure 4F).
To further test that decreased cholesterol and the consequent
reduction in the NMDA-CaMKII pathway contribute to the weak
NMDA-induced expression of Bdnf transcripts II and VI in old
mice, we reduced cholesterol in hippocampal slices from adultCNT, unstimulated control; LTD10, NMDA treated. Data are represented as mea
t test orMann-Whitney (B–H). The value inside the bars indicates the number of ind
***p < 0.001) obtained in the comparisons to controls indicated as a dashed line
Supplemental Information.8-month-old mice by treating with COase before LTD induction.
COase treatment of the slices from adult mice impaired the acti-
vation of CaMKII and CREB 10 min after NMDA stimulation (Fig-
ures S3A and S3B). Moreover, COase treatment of slices from
adult mice impaired LTD-induced chromatin remodeling and
Bdnf transcription (Figures S3C–S3F).
H3K27Me3 Demethylation at Bdnf Promoters Is
Cholesterol Dependent
We performed ChIP to investigate whether cholesterol affects
levels of the repressive modification H3K27Me3 at the Bdnf
promoter. We found that cholesterol treatment of old slices re-
sulted in decreased basal levels of the repressive mark
H3K27Me3, which required NMDAR signaling, because it was
prevented by the NMDA antagonist AP5 (Figure 5A). Further-
more, COase-mediated cholesterol depletion of slices obtained
from 8-month-old mice resulted in higher levels of H3K27Me3 at
Bdnf promoters II and VI (Figure 5B). We also found that the
reduction in H3K27Me3 levels triggered by LTD is impaired in
old neurons (Figure 5C). The chemical LTD-induced reduction
in H3K27Me3 is enhanced by cholesterol treatment of slices
from old mice and prevented by COase-mediated cholesterol
reduction in slices from adult mice (Figure 5C). Thus, mem-
brane cholesterol controls the levels of H3K27Me3 at Bdnf pro-
moters through the NMDAR-CaMKII pathway, probably via the
H3K27Me3 demethylase JMJD3, which we have shown to be re-
cruited to the Bdnf promoters by the CREB/CBP complex (see
Palomer et al., 2016).
Prevention of Age-Associated Cholesterol Loss
RescuesHippocampalBdnfTranscription andEnhances
Cognition in Old Mice
Based on these results, we hypothesized that preventing the hip-
pocampal cholesterol loss that occurs during aging may rescue
the membrane signaling and epigenetic changes at Bdnf pro-
moters and may ameliorate some of the cognitive deficits typical
of this stage of life. The age-associated reduction in hippocampal
cholesterol arises partly from increased expression of the
Cyp46A1 gene, which encodes the major cholesterol catabolic
enzyme in the brain (Cyp46; Lund et al., 1999). High levels of
Cyp46 were observed in the hippocampus of elderly humans
and in patientswith certain pathological, neurodegenerative con-
ditions (reviewed in Martı´n et al., 2014b). To test this hypothesis,
we inhibited Cyp46 activity in old mice by treating them with the
antifungal azolic derivative voriconazole. Voriconazole inhibits
the enzyme sterol-14a-demethylase (Cyp51) in fungi, which is
involved in the ergosterol synthesis, but targets Cyp46 in
mammalian cells (Shafaati et al., 2010). Previous work estab-
lished that intraperitoneal voriconazole crosses the blood-brain
barrier, effectively inhibiting Cyp46 activity (Shafaati et al.,
2010). Voriconazole was administrated to 19-month-old mice in
their drinking water for 45 days. We observed a significant
decrease in the age-associated loss of cholesterol in then ± SEM. Statistical analysis by ANOVA or Kruskal-Wallis (A) and one-sample
ependent experiments; the asterisks indicate the p values (*p < 0.05; **p < 0.01;
(A–D) or labeled as CNT (E–H). For specific statistical analysis and data, see
Cell Reports 16, 2889–2900, September 13, 2016 2893
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Figure 3. Cholesterol Rescues the Bdnf Epigenetic State through NMDAR Activation in Old Hippocampal Slices
(A) Cholesterol quantification of adult and old hippocampus.
(B) Cholesterol quantification of control and MßCD-Ch-treated old hippocampal slices.
(C and D) ChIP analysis showing the levels of H3K27Ac (C) and HDAC4 (D) bound at Bdnf promoters in hippocampal slices from old mice treated with MßCD-Ch
and/or AP5. The data are expressed as relative values with respect to untreated controls (dashed line).
(E) Western blot and its quantification, showing the levels of active and total aCaMKII in control or MßCD-Ch-treated old hippocampal slices.
(F) ChIP analysis showing the levels of CBP bound at Bdnf promoters in hippocampal slices from old mice treated with MßCD-Ch and/or AP5.
(G) Western blot and its quantification, showing the levels of phosphorylated and total CREB in control or MßCD-Ch-treated old hippocampal slices.
Data are represented as mean ± SEM. Statistical analysis by Student’s t test or one-sample t test (A, B, E, and G) and ANOVA or Kruskal-Wallis (C, D, and F). The
value inside the bars indicates the number of animals or independent experiments; asterisks indicate *p < 0.05; **p < 0.01; ***p < 0.001 compared to adult samples
(A) or untreated samples, indicated as a minus sign (B, E, and G) or dashed line (C, D, and F). For specific statistical analysis, see Supplemental Information.
2894 Cell Reports 16, 2889–2900, September 13, 2016
A B C
D E F
Figure 4. Cholesterol Rescues Bdnf Induction by NMDA-LTD in Old Hippocampus
(A–C) The ChIP analysis shows that NMDA stimulation triggers the recruitment of CBP and H3K27 acetylation (A and B) and the decrease of HDAC4 (C) at Bdnf
promoters II and VI in old hippocampal slices pretreated with MßCD-Ch to restore the normal levels of this lipid. These changes are not observed in cholesterol-
untreated old samples (). The asterisks indicate the p values obtained by comparison of NMDA-stimulated samples with their own unstimulated controls, taken
as reference (value = 1, dashed line).
(D and E) Western blot and its quantification, showing the levels of active and total aCaMKII and CREB in cholesterol-untreated slices (UN), MßCD-Ch-treated
slices, unstimulated controls (CNT), and MßCD-Ch-treated, NMDA-stimulated (LTD10), old hippocampal slices. Reactivation of the NMDAR-CaMKII pathway by
cholesterol leads to CREB and CaMKII phosphorylation in basal conditions. NMDA stimulation leads to further activation of these proteins.
(F) qRT-PCR analysis showing that MßCD-Ch treatment in old hippocampal slices rescues the induction of Bdnf promoters II and VI by NMDA. Cholesterol-
treated (MßCD-Ch) or cholesterol-untreated () slices were stimulated with NMDA, samples were taken at 10 and 30 min after stimulation and compared to each
unstimulated control (dashed line).
Data are represented as mean ± SEM. Statistical analysis was performed by one-sample t test (A–E) and ANOVA or Kruskal-Wallis (F). The value inside the
bars indicates the number of animals or independent experiments; asterisks indicate *p < 0.05; **p < 0.01; for specific statistical analysis, see Supplemental
Information.hippocampusof voriconazole-treatedmice compared to vehicle-
treated animals (Figure 6A). Furthermore, we observed increased
levels of Bdnf transcripts II and VI 10 and 30 min after LTD
induction of hippocampal slices from voriconazole-treated
mice (Figure 6B). In contrast, low transcriptional induction was
observed after LTD induction of slices from the vehicle-treated
group. Voriconazole treatment also resulted in increased levels
of H3K27Ac and decreased levels of H3K27Me3 at Bdnf pro-
moters II and VI after LTD (Figures 6C and 6D). Thus, the partial
rescue of cholesterol levels in mice treated with voriconazole
was paralleled by epigenetic changes at Bdnf promoters and
by improved LTD-induced response.To determine whether voriconazole treatment improves the
cognitive abilities of old mice, voriconazole- or vehicle-treated
mice were subjected to three behavioral tests: novel object loca-
tion, Morris water maze, and contextual fear conditioning. In the
novel location task, the exploration phase was similar in vorico-
nazole- or vehicle-treated animals; however, during the retention
session, animals chronically treated with voriconazole spent
more time exploring the object that was placed in a novel posi-
tion, indicating better spatial memory than vehicle-treated mice
(Figure 6E).
In the hidden-platform version of the Morris water maze test,
which evaluates hippocampal function, both groups showedCell Reports 16, 2889–2900, September 13, 2016 2895
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Figure 5. H3K27Me3 Demethylation at Bdnf Promoters Requires
Cholesterol and NMDAR Activity in Old Neurons
(A) ChIP analysis showing the levels of H3K27Me3 bound at Bdnf promoters
in hippocampal slices from old mice treated with MßCD-Ch and/or AP5.
H3K27Me3 demethylation is observed when cholesterol is replenished in old
hippocampal slices but not when cholesterol is added in the presence of AP5.
No significant differences were observed in neurons treated with AP5.
(B)ChIP analysis showing that cholesterol depletion (COase) results in increased
H3K27Me3 bound to Bdnf promoters compared to untreated controls.
(C) ChIP results showing that H3K27Me3 demethylation is triggered by LTD in
adult but not in old neurons. Cholesterol depletion (COase) in adults impairs
2896 Cell Reports 16, 2889–2900, September 13, 2016improved performance during all successive trials throughout
the 4 days of spatial training. Path length, swimming speed,
and time to reach the platform were unchanged by the treat-
ment, indicating that controls and voriconazole-treated animals
learned the location of the platform at an equivalent rate (Figures
S4A–S4E). However, in the memory probe test, voriconazole-
treated animals spent significantly more time in the target quad-
rant compared with the controls, indicating that voriconazole
improved spatial reference memory (Figure 6F).
In the cued fear-conditioning training test, both groups dis-
played similar levels of freezing before, during, and after
tone-shock pairings (Figure S4F). However, in the contextual
fear-conditioning test, which is primarily contingent on hippocam-
pal function, voriconazole-treated animals exhibited improved
memory recall compared to controls (Figure 6G; Figure S4G).
During the auditory-cued fear memory test, which depends on
amygdala but not hippocampal function, both animal groups
displayed similar freezing behavior (Figure S4H) and similar
sensitivity to the electric shock. These findings suggest that
voriconazole increases contextual fear conditioning through an
improvement of hippocampal function.
In addition to the beneficial effects of long-term treatment with
voriconazole, we found that short-term voriconazole treatment
restores synaptic function. We treated hippocampal slices ob-
tained from old mice with 10 nM voriconazole for 2 hr and
observed rescue of NMDA-LTD (Figures S5A and S5B). Finally,
to link the effects of voriconazole with NMDA signaling, we
analyzed the levels of PSD95 and the NMDAR subunit NR1 in
control and in voriconazole-treated old mice. We found that
the total levels of PSD95 do not change with voriconazole treat-
ment, neither in total hippocampal extract nor in hippocampal
synaptosomal fraction (Figures S6A and S6B). However, NR1
levels increase in the synaptic fraction of voriconazole-treated
mice, without a change in total levels of NR1 (Figures S6C and
S6D). These findings suggest the beneficial effects of voricona-
zole may be mediated partly by the more efficient recruitment of
NMDAR to synapses. This possibility is in line with the work of
Korinek et al. (2015), who showed that NMDAR activity is
impaired in low-cholesterol contexts, without changes in total
surface NMDAR.DISCUSSION
The existence of a functional link between changes in the brain
cholesterol content and cognitive deficits is anticipated: choles-
terol is an essential constituent of eukaryotic membranes, and as
such, any alteration in this sterol will have an impact on the func-
tion of brain cells. Intuitively, a change in cholesterol contentdemethylation, whereas it is rescued by cholesterol replenishment in old slices
(MßCD-Ch). The values show the levels of H3K27Me3 10 min after NMDA
stimulation with respect to unstimulated controls.
Data are represented asmean ± SEM. Statistical analysis by Kruskal-Wallis (A)
or one-sample t test (B and C). The value inside the bars indicates the number
of animals or independent experiments; asterisks indicate *p < 0.05; **p < 0.01
compared untreated or control samples, indicated as a dashed line. For
specific statistical analysis, see Supplemental Information.
A B
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Figure 6. Oral Administration of Voricona-
zole to Old Mice Rescues Bdnf Epigenetic
Regulation and Transcription after LTD and
Improves Behavior
(A) Cholesterol quantification in hippocampus of
voriconazole- and vehicle-treated old mice.
(B) Levels of mRNAs transcribed from promoters II
and VI after LTD in hippocampal slices of vor-
iconazole- or vehicle-treated mice.
(C and D) ChIP analysis showing the levels of
H3K27Ac and H3K27Me3 at these Bdnf promoters
10 min after NMDA stimulation in hippocampal
slices of voriconazole- or vehicle-treated mice.
(E–G)Behavioral testsofoldmice treated for45days
with voriconazole or vehicle. (E) Object location
memory test, (F) Morris water maze spatial memory
test, and (G) contextual fear-conditioning test.
Veh, vehicle; Vori, voriconazole. Data are repre-
sented as mean ± SEM. Statistical analysis by Stu-
dent’s t test (A and E–G) or one-sample t test (C and
D) and ANOVA (B). The value inside the bars in-
dicates the number of animals or independent ex-
periments; asterisks indicate *p < 0.05; **p < 0.01;
***p < 0.001 compared to vehicle (A and E–G) or to
control, indicatedasadashed line (B–D). Forspecific
statistical analysis, see Supplemental Information.could lead to cognitive alterations by both short- and long-range
actions. Synaptic transmission is particularly sensitive to a
disturbance in cholesterol levels, probably because synaptic
vesicle release at the presynaptic terminal and the response to
signals through neurotransmitter receptors on the postsynaptic
side rely entirely on membranous compartments and mem-
brane-bound signaling pathways, many of which depend on
the integrity of cholesterol-rich microdomains (reviewed in Her-
ing et al., 2003; Ledesma et al., 2012; Renner et al., 2009). The
long-range action of cholesterol would be via the regulatory
role that membrane cholesterol plays on membrane receptors,
likely influencing the activity of downstream kinases, e.g.,
p38MAPK or MSK1/2, which can influence gene expression by
phosphorylating chromatin proteins (Gehani et al., 2010; Pal-
omer et al., 2016). We demonstrate that the loss of cholesterol
in the hippocampus of old mice contributes to the impairedCell Reportsinduction of two key Bdnf promoters in
response to a cognitive stimulus. We
discovered that old hippocampal neurons
have a reduced capacity to activate the
biochemical signals normally arising by
NMDAR stimulation; as a consequence,
the epigenetic remodeling that leads to
transcriptional stimulation of Bdnf pro-
moters II and VI by LTD does not occur.
All these events were rescued by directly
increasing cholesterol levels in the hippo-
campus of old mice or by preventing age-
associated brain cholesterol loss.
Although a reduced cholesterol envi-
ronment promotes the repressive epige-
netic state at Bdnf promoters, it does
not seem to be the only factor responsiblefor the low basal expression of Bdnf promoters II and IV found in
elderly mice. Cholesterol treatment of old, unstimulated neurons
was not sufficient to increase the basal levels of these tran-
scripts, despite enhanced CaMKII activity and altered features
at the Bdnf promoters associated with active transcription,
including reduced binding of HDAC4, depletion of H3K27Me3,
enrichment of H3K27A, and increased binding of CBP. However,
the cholesterol replenishment rescued the ability of these
promoters to be transcriptionally induced by NMDA. From these
results, one could argue that cholesterol-dependent and choles-
terol-independent mechanisms coexist to restrict the transcrip-
tion of Bdnf promoters in the basal conditions and that all these
restrictions are removed after neuronal stimulation with NMDA in
the presence of normal levels of cholesterol.
One strong candidate to exert repression in the basal condi-
tion is HDAC2, which accumulates at the Bdnf promoters and16, 2889–2900, September 13, 2016 2897
seems to respond to a different, cholesterol-independent sig-
naling pathway in the old (Figure S1B). Another candidate is
the repressor protein CDYL, which is present at Bdnf promoter
II and can be degraded by NMDA or KCl stimulation (Palomer
et al., 2016; Qi et al., 2014). In this case, the reactivation of the
NMDAR-CaMKII pathway by cholesterol in the basal state would
not be sufficient to trigger CDYL degradation, though a stronger
signal induced by treatment with NMDA and cholesterol could
lead to CDYL degradation and promoter induction. Another pos-
sibility is that cholesterol replenishment per se is not sufficient
to restore Bdnf expression in unstimulated old neurons due to
an age-associated reduction of a putative transcriptional acti-
vator. Along these lines, one could speculate that an age-related
decay of SIRT1may promote the inhibition of CREB synthesis by
microRNA (miRNA) 134 (Gao et al., 2010), resulting in low levels
of CREB with age. However, we did not observe a decrease in
the total levels of SIRT1 or CREB in old hippocampi compared
with adult ones (Figures S1D and S1E). Furthermore, the rescue
of Bdnf expression after LTD in cholesterol-treated old hippo-
campi was not accompanied by a change in the total levels of
SIRT1 or CREB (Figures S1F and S1G). Future work is needed
to dissect the full mechanisms repressing Bdnf transcription in
old mice.
However, the reduction of hippocampal cholesterol with age
seems to play an important role in the age-associated impair-
ment of NMDA-induced Bdnf transcription. Treatment of old
neurons with cholesterol improved NMDAR signaling toward
CaMKII. Cholesterol treatment of old neurons was also required
for NMDA-induced changes at the Bdnf promoter, including
depletion of phosphorylated HDAC4, CREB activation, CREB-
p/CBP recruitment, and increased H3K27Ac levels, and for
NMDA-LTD-induced expression from Bdnf promoters II and VI.
Pre-treatment of old neurons with the NMDAR antagonist AP5
abrogated the effects of cholesterol, indicating the attenuated
NMDAR signaling arising from reduced cholesterol levels under-
lie the epigenetic changes at the Bdnf promoter. Low cholesterol
levels may perturb the organization or dynamics of receptors in
the plasmamembrane. It was recently shown that reduced levels
of cholesterol in the plasma membrane result in defective AMPA
receptor recycling in hippocampal neurons from oldmice (Martin
et al., 2014a).
Cholesterol reduction in the aged hippocampus may have
several causes. Among these, increased transcription of
Cyp46A1 has been proposed to explain cholesterol reduction
in a number of circumstances (reviewed in Martı´n et al.,
2014b). Cyp46 hyper-activation has been observed in cells sub-
jected to stress in vitro (Lund et al., 1999; Sodero et al., 2011a,
2011b) and in Alzheimer’s brains and in other brain pathologies
with abundant stress (Bogdanovic et al., 2001; Cartagena
et al., 2008; Teunissen et al., 2007). Our current results, based
on the use of the Cyp46 inhibitor voriconazole, also fit with this
hypothesis: oral administration of voriconazole in aged mice
reduced the typical cholesterol loss associated with aging,
favored a transcriptionally poised epigenetic state at Bdnf
promoters, and improved cognitive abilities. In light of these ob-
servations, we can conclude that, as proposed by Murphy and
Partridge (2008),Cyp46A1may be one of the upregulated genes
responsible for the aging phenotype of the mammalian brain.2898 Cell Reports 16, 2889–2900, September 13, 2016Furthermore, its inhibition appears a likely target to prevent or
mitigate, at least to a certain extent, the cognitive deficits of
the aged. Knockoutmice constitutively lackingCyp46A1 expres-
sion exhibit severe deficiencies in spatial, associative, andmotor
learning associated to developmental defects (Kotti et al., 2006).
Therefore, in light of our findings, one can envision the following
scenario: when at basal levels of expression, as occurs during
development and in adulthood, Cyp46’s activity may be essen-
tial for optimal cognition; when activity is abnormally high, for
instance, during aging or chronic stress conditions (Alzheimer’s),
Cyp46’s activity may be deleterious. Tissue-specific inducible
knockout of Cyp46A1 may help to address this question.
We have previously described the immediate consequences
of age-associated cholesterol loss in neurons and how these
may contribute to the cognitive deficits of the old (Martin et al.,
2014a). Here, we show that decreased hippocampal cholesterol
levels in old mice disrupt NMDAR activation and, in turn, epige-
netic regulation ofBdnf and likely other immediate early-memory
genes (Figures S6E and S6F). Pharmacological inhibition of
Cyp46, the enzyme responsible for the major brain cholesterol
catabolic pathway (Lund et al., 2003), rescued the behavioral
deficits and associated poor induction of Bdnf by cognitive stim-
uli in agedmice, suggesting that the cognitive decline associated
with aging may be reversible.
EXPERIMENTAL PROCEDURES
Animal Handling
All experiments were performed in accordance with European Union guide-
lines (2010/63/UE) regarding the use of laboratory animals.
Hippocampal Slices
Hippocampal slices were prepared from C57BL/J adult (8 ± 2 months old)
mice and old (20 ± 1 month old) mice. Hippocampi were extracted in
dissection solution (10 mM D-glucose, 4 mM KCl, 26 mM NaHCO3,
233.7 mM sucrose, 5 mM MgCl2, 1:1,000 phenol red), oxygen saturated
with carbogen (95% O2/5% CO2), and sliced in an automatic tissue chopper
(McIlwain Tissue Chopper, Standard Table, 220 V, Ted Pella) to obtain
400 mm hippocampal slices. Then, slices were kept for 1 hr in artificial cerebro-
spinal fluid (ACSF; 119 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4, 11 mM
glucose, 1.2 mM MgCl2, 2.5 mM CaCl2). (Osmolarity was adjusted to
290 Osm, and ACSF was oxygen saturated with carbogen.) Finally, the exper-
iments were performed in ACSF.
Statistical Analysis
All values are presented as mean + SEM. Data normality and variances were
tested by the Shapiro-Wilk test and Levene test, respectively. For non-para-
metric values, comparisons between two groups of data were analyzed by
Mann-Whitney U test, comparisons between more than two groups were
analyzed by Kruskal-Wallis. The Friedman test was used to analyze behavioral
studies. For normal distributed data, parametric tests were used. Compari-
sons between two groups were analyzed by Student’s t test. If no equal
variances were found in one of the groups, the statistical test applied was
one-sample t test. For comparisons of more than two groups of data,
ANOVA was used; post hoc was performed assuming or not assuming equal
variances. In the figures, asterisks indicate p values as follows: *p < 0.05;
**p < 0.01; ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and twelve tables and can be found with this article online at
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